Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
Tarsus Pharmaceuticals, Inc.
Business Segments
Business Segments
Business Segments
13 metrics
Total revenues
Cost of Sales
R&D
Sales & Marketing
SG&A
Costs and Expenses
Operating Income (Loss)
Other reconciling items
Net loss
Interest Income
Interest Expense, Nonoperating
Depreciation and amortization expense
Provision for income taxes
Watchlist
Screener
Filings
Earnings
Charts